<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
      <JournalTitle>International Journal of Clinical Investigation and Case Reports</JournalTitle>
      <Volume-Issue>Volume 1, Issue 2</Volume-Issue>
      <ArticleTitle>Infant Botulism: Rare but Very Dangerous Event: A Case Report</ArticleTitle>
          <FirstName>Lasorella ML*</FirstName>
      <Abstract>We report a case of infant botulism admitted to the Children__ampersandsign#39;s Hospital __doublequotosingGiovanni XXIII”, Bari, Italy. After a week of constipation, hypotonia, lethargy, ptosis, reduction of suction and cry, a 2-month-old infant male, the first kid of unrelated parents was taken to the closest hospital, after being born normotrophic, at term, without a prenatal, perinatal, or postnatal medical history or neurodevelopmental delay. The patient was referred to the pediatric center for an undiagnosed progressive worsening of awareness and he was intubated for bradypnea and desaturation. The toxicologic panel, cerebrospinal fluid exam, radiological imaging, and laboratory results were negative. Only after neurological instrumental analysis, we found a normal EEG but a positive EMG that is associated with the history of raw honey intake (revealed only later by his mother). We were allowed to define the hypothesis of infant botulism earlier than the confirmation of the standard mouse bioassay. So, as a result, Botulism Immune Globulin-Intravenous IgG over 3 hours in a single recommended dose of 0.1 mL/kg/min was injected. The infant showed a gradual improvement and after 10 days he was extubated. The Preterm Oral Feeding Readiness Scale showed an improvement through the rehabilitation program with physiotherapy and parents’ stimuli. After one month he was discharged. Frequently, infant botulism is not the first hypothesis but it is the result of a strict differentiation from other diseases characterized by hypotonia such as sepsis, infectious, genetic, autoimmune, or metabolic diseases through the use of history, and laboratory tests and radiological imaging. At first, toxin detection can be useful for early diagnosis. In the later stages, the neurological instrumental support can help the clinician to elucidate the cause of muscle weakness. In fact, the EEG and the EMG could be positive when toxins are unlikely to be detectable in the serum and other data are negative. A minimum of one arm and one leg should be examined for motor and sensory nerve conduction velocity along with two distal muscles for 2-Hz nerve stimulation and a needle EMG with an adequate sample. We suggest that the neurological instrumental support can help the clinician to elucidate the cause of muscle weakness, in particular in the later stages. Honey shouldn__ampersandsign#39;t be provided to infants under one-year-old children because the majority of instances still have a good history of exposure to it.</Abstract>
      <Keywords>Infant Botulism ,Diagnosis,Hypotonia ,Electromyography ,Botulism Immune Globulin-Intravenous IgG ,Preterm Oral Feeding Readiness Scale</Keywords>
        <Abstract>https://ijcicr.com/ubijournal-v1copy/journals/abstract.php?article_id=14041&amp;title=Infant Botulism: Rare but Very Dangerous Event: A Case Report</Abstract>
        <References>Rossetto O, Pirazzini M, Montecucco C. Botulinum neurotoxins: genetic, structural and mechanistic insights. Nat Rev Microbiol. 2014;12(8):535-549.&#13;
	Simpson L. The life history of a botulinum toxin molecule. Toxicon. 2013;68:40-59.&#13;
	Snowdon JA. Infant botulism: an overview. For the National Honey Board. 1997; 1-12.&#13;
	Censi A, Cremasco S, Maggi E. Clostridium spp. nel miele. Atti SIS Vet. 1989;43:125-129.&#13;
	Griglio B, Galvagno G, Sattanino G, Rossignoli M, Musella C. Il botulismo infantile: il ruolo del miele. AIVEMP Newsletter. 2004.&#13;
	Koepke R, Sobel J, Arnon SS. Global occurrence of infant botulism, 1976-2006. Pediatrics. 2008;122(1):e73-e82.&#13;
	Mitchell WG, Tseng-Ong L. Catastrophic presentation of infant botulism may obscure or delay diagnosis. Pediatrics. 2005;116(3):e436-e438.&#13;
	Schmidt RD, Schmidt TW. Infant botulism: a case series and review of the literature. J emergency med. 1992;10(6):713-718.&#13;
	Cochran DP, Appleton RE. Infant Botulism–Is It That Rare?. Dev Med Child Neurol. 1995;37(3):274-8.&#13;
	Peredo DE, Hannibal MC. The floppy infant: evaluation of hypotonia. Pediatr Rev. 2009;30(9):e66-e76.&#13;
	Francisco AM, Arnon SS. Clinical mimics of infant botulism. Pediatrics. 2007;119(4):826-8&#13;
	Muensterer O. Infant botulism. Pediatr Rev. 2000;21:427&#13;
	Domingo RM, Haller JS, Gruenthal M. Infant botulism: two recent cases and literature review. J Child Neurol. 2008;23(11):1336-1346.&#13;
	Cox N, Hinkle R. Infant Botulism. Am Fam Physician. 2002;65 (7):1388-1393.&#13;
	Gutierrez AR, Bodensteiner J, Gutmann L. Topical Review: Electrodiagnosis of Infantile Botulism. J child neurol. 1994;9(4):362-366.&#13;
	Arnon SS, Schechter R, Inglesby TV, et al. Botulinum toxin as a biological weapon: medical and public health management. JAMA. 2001;285(8):1059-1070.&#13;
	Johnson RO, Clay SA, Arnon SS. Diagnosis and management of infant botulism. Am J Dis Child. 1979;133(6):586-593.&#13;
	Volpe JJ. The Neurological Manifestations of Pediatric Infectious Diseases and Immunodeficiency Syndromes. Springer Science and; Business Media. 2008.&#13;
	Long SS. Infant botulism. Pediatr Infect Dis J. 2001;20(7):707-709.&#13;
	Schreiner MS, Field E, Ruddy R. Infant botulism: a review of 12 yearsand;#39; experience at the Childrenand;#39;s Hospital of Philadelphia. Pediatrics. 1991;87(2):159-165.&#13;
	Arnon S, Barzilay E, Kimberlin DW. Clostridial infections: botulism and infant botulism (Clostridium botulinum). Red Book. 30th ed. Elk Grove Village, IL: Am Acad Ped. 2015:294-296.&#13;
	Midura TF. Update: infant botulism. Clin Microbiol Rev 1996;9:119-125.&#13;
	Arnon SS, Schechter R, Maslanka SE, et al. Human botulism immune globulin for the treatment of infant botulism. N Engl J Med. 2006;354(5):462-471.&#13;
	Underwood K, Rubin S, Deakers T, et al. Infant botulism: a 30-year experience spanning the introduction of botulism immune globulin intravenous in the intensive care unit at Childrens Hospital Los Angeles. Pediatrics. 2007;120(6):e1380-e1385.&#13;
	Bernardor J, Neveu J, Haas H, et al. Infant botulism: Two case reports and electroneuromyogram findings. Archives de Pediatrie. 2018;25(5):340-343.&#13;
	Shiva Ramroop, Bhanu Williams, Surabhi Vora, Karyn Moshal. Infant botulism and botulism immune globulin in the UK: a case series of four infants. Arch Dis Child. 2012;97(5):459-460.</References>